| Primary |
| Still's Disease Adult Onset |
100.0% |
|
| Transaminases Decreased |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.1% |
| Pyrexia |
10.3% |
| Hypertension |
10.0% |
| Overdose |
5.7% |
| Spinal Column Stenosis |
5.7% |
| Suicide Attempt |
5.7% |
| Product Used For Unknown Indication |
4.6% |
| Cancer Pain |
4.1% |
| Prophylaxis |
3.5% |
| Chronic Hepatitis C |
3.3% |
| Rectal Cancer |
3.3% |
| Febrile Neutropenia |
3.2% |
| Gastritis |
3.0% |
| Insomnia |
3.0% |
| Adult T-cell Lymphoma/leukaemia |
2.9% |
| Constipation |
2.9% |
| Headache |
2.9% |
| Pain |
2.9% |
| Duodenal Ulcer Perforation |
2.5% |
| Rash |
2.5% |
|
| Rash |
8.1% |
| Hepatic Function Abnormal |
7.0% |
| Pyrexia |
7.0% |
| Urticaria |
7.0% |
| White Blood Cell Count Increased |
7.0% |
| Duodenal Ulcer Perforation |
5.8% |
| Interstitial Lung Disease |
5.8% |
| Tubulointerstitial Nephritis |
5.8% |
| Eosinophilia |
4.7% |
| Pancytopenia |
4.7% |
| Pneumonia Aspiration |
4.7% |
| Renal Impairment |
4.7% |
| Thrombotic Thrombocytopenic Purpura |
4.7% |
| Wheezing |
4.7% |
| Multi-organ Failure |
3.5% |
| Skin Exfoliation |
3.5% |
| Stevens-johnson Syndrome |
3.5% |
| Vanishing Bile Duct Syndrome |
3.5% |
| Activated Partial Thromboplastin Time Prolonged |
2.3% |
| Autoimmune Hepatitis |
2.3% |
|
| Concomitant |
| Prophylaxis |
17.4% |
| Product Used For Unknown Indication |
9.8% |
| Behcet's Syndrome |
8.5% |
| Rheumatoid Arthritis |
8.5% |
| Hepatitis C |
7.3% |
| Chronic Hepatitis C |
7.2% |
| Drug Use For Unknown Indication |
6.8% |
| Cancer Pain |
5.3% |
| Hypertension |
4.6% |
| Pain |
4.1% |
| Constipation |
3.8% |
| Gastritis Prophylaxis |
2.8% |
| Insomnia |
2.5% |
| Metastatic Renal Cell Carcinoma |
2.3% |
| Diabetes Mellitus |
2.0% |
| Colon Cancer Recurrent |
1.6% |
| Prostate Cancer Stage Iv |
1.5% |
| Colon Cancer |
1.4% |
| Back Pain |
1.3% |
| Gastritis |
1.2% |
|
| White Blood Cell Count Decreased |
16.3% |
| Interstitial Lung Disease |
8.8% |
| Pyrexia |
7.0% |
| Pneumonia |
5.4% |
| Stomatitis |
5.4% |
| Vomiting |
5.2% |
| Renal Impairment |
5.0% |
| Glaucoma |
4.8% |
| Hepatic Function Abnormal |
4.8% |
| Malaise |
4.1% |
| Platelet Count Decreased |
3.9% |
| Haemoglobin Decreased |
3.6% |
| Somnolence |
3.6% |
| Pleural Effusion |
3.4% |
| Prostate Cancer |
3.4% |
| Rash |
3.4% |
| Neutrophil Count Decreased |
3.2% |
| Renal Failure Acute |
2.9% |
| Retinopathy |
2.9% |
| Lymphoma |
2.7% |
|
| Interacting |
| Mycobacterial Infection |
36.4% |
| Atypical Mycobacterial Infection |
27.3% |
| Drug Use For Unknown Indication |
18.2% |
| Metastases To Meninges |
18.2% |
|
| Pancytopenia |
40.0% |
| Drug Interaction Potentiation |
20.0% |
| Interstitial Lung Disease |
20.0% |
| Lung Disorder |
20.0% |
|
